ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36165
-0.01%
Bitcoin
67,127.59
0.07%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX
  6. Knight Therapeutics Inc (GUD)

  7. Knight Therapeutics Inc (GUD) News

GUD

Knight Therapeutics (GUD)

Knight Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:GUD
DateTimeSourceHeadlineSymbolCompany
08/10/202310:00AMAllPennyStocks.comTrading For This Specialty Pharma Company is up Following Second Quarter ResultsTSX:GUDKnight Therapeutics Inc
05/13/20218:38AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - GUDTSX:GUDKnight Therapeutics Inc
05/13/20218:37AMPR Newswire (Canada)IIROC Trade Resumption - GUDTSX:GUDKnight Therapeutics Inc
05/13/20217:25AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - GUDTSX:GUDKnight Therapeutics Inc
05/13/20217:24AMPR Newswire (Canada)IIROC Trading Halt - GUDTSX:GUDKnight Therapeutics Inc
05/03/20215:00AMPR Newswire (Canada)Maverix Private Equity Announces Team AdditionsTSX:GUDKnight Therapeutics Inc
05/03/20215:00AMPR Newswire (US)Maverix Private Equity Announces Team AdditionsTSX:GUDKnight Therapeutics Inc
12/11/20204:15PMPR Newswire (Canada)S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite IndexTSX:GUDKnight Therapeutics Inc
12/11/20204:15PMPR Newswire (Canada)S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSXTSX:GUDKnight Therapeutics Inc
01/08/20207:00AMPR Newswire (US)Knight Partners With Debiopharm for the Commercialization of Trelstar® in CanadaTSX:GUDKnight Therapeutics Inc
06/18/20194:00PMPR Newswire (US)Medimetriks Pharmaceuticals Focuses on Advancing MM36 (difamilast) Through Phase 3 Trials; Extinguishes Debt Owed to Knight T...TSX:GUDKnight Therapeutics Inc
04/29/20197:45AMPR Newswire (Canada)Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Q...TSX:GUDKnight Therapeutics Inc
04/25/20199:21AMPR Newswire (Canada)Leading Independent Proxy Advisory Firm ISS Recommends Change at Knight TherapeuticsTSX:GUDKnight Therapeutics Inc
04/18/20198:00AMPR Newswire (Canada)Medison Issues Presentation to Knight ShareholdersTSX:GUDKnight Therapeutics Inc
04/17/20196:00AMPR Newswire (Canada)Leading Canadian Corporate Governance Expert Confirms Acute Board Conflicts and Governance Deficiencies at Knight Therapeutic...TSX:GUDKnight Therapeutics Inc
04/16/20197:30AMPR Newswire (Canada)Medison Issues Letter to Shareholders of Knight Therapeutics, Outlining Qualified, Independent Director Nominees and Common-S...TSX:GUDKnight Therapeutics Inc
04/10/20197:39AMPR Newswire (Canada)Medison Disappointed that Knight Therapeutics has Resorted to Blatant Misrepresentations to Avoid ScrutinyTSX:GUDKnight Therapeutics Inc
04/08/20197:00AMPR Newswire (Canada)Medison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehen...TSX:GUDKnight Therapeutics Inc
04/01/20197:00AMPR Newswire (Canada)Medison to Nominate Six Highly Qualified Directors for Knight Therapeutics' Board to Strengthen Oversight and Drive Value Cre...TSX:GUDKnight Therapeutics Inc
02/18/20197:30AMPR Newswire (US)Knight Signs GUD (Bueno) Latin American Strategic Funding Deal with Moksha8TSX:GUDKnight Therapeutics Inc
03/19/20185:30AMPR Newswire (US)Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in CanadaTSX:GUDKnight Therapeutics Inc
02/08/20188:21AMPR Newswire (US)60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria DrugTSX:GUDKnight Therapeutics Inc
02/08/20188:03AMPR Newswire (US)60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria DrugTSX:GUDKnight Therapeutics Inc
01/04/20188:45AMPR Newswire (US)60 Degrees Pharmaceuticals Fast Tracked For Malaria DrugTSX:GUDKnight Therapeutics Inc
12/18/20178:00AMPR Newswire (US)60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug TafenoquineTSX:GUDKnight Therapeutics Inc
08/14/20174:30PMMarketwiredSynergy CHC Corp. Announces Second Quarter 2017 ResultsTSX:GUDKnight Therapeutics Inc
06/13/20177:03AMPR Newswire (Canada)Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid...TSX:GUDKnight Therapeutics Inc
06/13/20177:03AMPR Newswire (US)Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid...TSX:GUDKnight Therapeutics Inc
12/09/20165:17PMPR Newswire (Canada)Indices S&P Dow Jones annonce des modifications à certains indices canadiens S&P/TSXTSX:GUDKnight Therapeutics Inc
03/22/20166:59AMPR Newswire (US)Profounda, Inc. launches Impavido® (miltefosine), the first and only oral Rx treatment for visceral, mucosal and cutaneous l...TSX:GUDKnight Therapeutics Inc
 Showing the most relevant articles for your search:TSX:GUD

Your Recent History

UNSW
DMTETH
Dark Matter Token
USOTC
PCNT
Point of Care Nano Techn... (CE)
BIT
UC277Z
Unicredit Bank
GATE
GGMUSDT
Monster Galaxy
AMEX
CRMD
CorMedix
LSE
AA77
Citi Fun 24
LSE
FP88
Citi Fun 25
ASX
SACHB
Securitised Australian M...
COIN
CFDEUR
NASDAQ
AAYJZXX
Jpmorgan Chase Financial...
ASX
VASSWA
LATK
MGTUSDT
MOONGAME
BIT
F06339
Vontobel Financial Produ...
BIT
F17273
Vontobel Financial Produ...
COIN
MUSEUSD
Muse DAO
BIT
UB8J2G
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved